Search results
Doctors Warn About 3 New COVID Variants—What to Know About ‘FLiRT’ Strains
Prevention via Yahoo News· 6 days agoNew COVID-19 variants known as “FLiRT,” KP.2, KP.3, and KP.1.1, are spreading fast. Doctors explain...
What to make of the new COVID variants, FLiRT
MPR News· 19 hours agoAs much as we would all love to ignore COVID, a new set of variants that scientists call “FLiRT” is here to remind us that the virus is still with us....
Analyzing The Emergence Of Covid Variant KP.2 And Its Potential Impact
Forbes· 4 days agoLike influenza, an easily transmissible respiratory virus, SARS-CoV-2 mutates to evade the immune...
Live: Fauci testifies publicly before House panel on COVID origins, controversies
Seattle Times· 20 hours agoDr. Anthony Fauci, the top U.S. infectious disease expert until leaving the government in 2022,...
New findings show risk of death from COVID-19 lessens, but infection still can cause issues three...
Medical Xpress· 5 days agoThe bad news: COVID-19 patients who were hospitalized within the first 30 days after infection face...
COVID-19, mpox 'still here' as summer nears
The San Francisco Examiner· 4 days agoSummer in San Francisco is likely to bring morning fog and an increase in COVID-19 and mpox cases, infectious-disease experts told The Examiner. “It...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 hours agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, today announced new data demonstrating that its antibodies
DOH: New dashboard shows COVID-19 at ‘yellow’ activity level in Hawaii
KHON 2 Honolulu· 6 days ago“The new Respiratory Disease dashboard provides, in one place, a summary of what is happening with...
Jacksonville research group seeks participants for new COVID-19 vaccine trial
WJXT Jacksonville· 5 days agoResearchers at the Jacksonville Center for Clinical Research (JCCR) are recruiting people to...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 4 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of...
